UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 233

Sortiert nach

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Annals of oncology, 2004-01, Vol.15 (1), p.129-133

2004

Link zum Volltext

Verfügbarkeit prüfen

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2472-2479

2002

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

Annals of oncology, 2000-06, Vol.11 (6), p.685-690

2000

Link zum Volltext

Verfügbarkeit prüfen

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1131-1137

1997

Link zum Volltext

Verfügbarkeit prüfen

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2945-2953

1997

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

Leukemia, 2003-01, Vol.17 (1), p.45-51

2003

Link zum Volltext

Verfügbarkeit prüfen

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial

Annals of oncology, 2014-08, Vol.25 (8), p.1622-1628

2014

Link zum Volltext

Verfügbarkeit prüfen

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2

Annals of oncology, 2008-03, Vol.19 (3), p.560-565

2008

Link zum Volltext

Verfügbarkeit prüfen

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Blood, 2003-06, Vol.101 (11), p.4279-4284

2003

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Outcome of Diffuse Large B-Cell Lymphoma in Hepatitis C Virus–Positive Patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte Programs

Journal of clinical oncology, 2006-02, Vol.24 (6), p.953-960

2006

Link zum Volltext

Verfügbarkeit prüfen

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma

The New England journal of medicine, 2005-03, Vol.352 (12), p.1197-1205

2005

Link zum Volltext

Verfügbarkeit prüfen

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Journal of clinical oncology, 2000-08, Vol.18 (16), p.3025-3030

2000

Link zum Volltext

Verfügbarkeit prüfen

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial

Journal of clinical oncology, 2002-01, Vol.20 (2), p.467-475

Ferme, C.

2002

Link zum Volltext

Verfügbarkeit prüfen

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

The hematology journal : the official journal of the European Haematology Association, 2001, Vol.2 (6), p.378

2001

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

Cancer medicine (Malden, MA), 2018-03, Vol.7 (3), p.539-548

2018

Link zum Volltext

Verfügbarkeit prüfen

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Blood, 1997-11, Vol.90 (9), p.3727-3734

1997

Link zum Volltext

Verfügbarkeit prüfen

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen

Annals of oncology, 1996-11, Vol.7 (9), p.966-969

1996

Link zum Volltext

Verfügbarkeit prüfen

Scénarios professionnels. 1

1994

Link zum Volltext

Verfügbarkeit prüfen

Sarcome granulocytaire du pancréas sans autre localisation extra-pancréatique

La Presse médicale (1983), 2002-06, Vol.31 (22), p.1024-1026

2002

Link zum Volltext

Verfügbarkeit prüfen

Late cardiopulmonary toxicity after treatment for Hodgkin's disease

British journal of cancer, 1992-06, Vol.65 (6), p.908-912

1992

Link zum Volltext

Verfügbarkeit prüfen

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial

Blood, 2000-04, Vol.95 (7), p.2246-2252

2000

Link zum Volltext

Verfügbarkeit prüfen

In the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients ? A case-controlled analysis

Journal of clinical oncology, 1996, Vol.14 (1), p.240-248

1996

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin et shunt mystérieux

La Revue de médecine interne (Paris), 2001-06, Vol.22, p.279s-280s

2001

Link zum Volltext

Verfügbarkeit prüfen

Une LLC qui ne sait pas dire son diagnostic ?

La Revue de médecine interne (Paris), 2001-06, Vol.22, p.270s-271s

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(101)
Male
(68)
Female
(63)
Life Sciences & Biomedicine
(61)
Middle Aged
(61)
Science & Technology
(61)
Adult
(56)
Aged
(37)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Sciences Biologiques Et Medicales
(24)
Sciences Medicales
(24)
Adolescent
(22)
Life Sciences
(20)
Oncology
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Pharmacology. Drug Treatments
(16)
Antineoplastic Agents
(15)
Hematologic And Hematopoietic Diseases
(14)
Hematology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Characteristics and Outcome of Diffuse Large B-Cell Lymphoma in Hepatitis C Virus–Positive Patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte Programs

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen

Scénarios professionnels. 1

Sarcome granulocytaire du pancréas sans autre localisation extra-pancréatique

Late cardiopulmonary toxicity after treatment for Hodgkin's disease

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial

In the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients ? A case-controlled analysis

Hodgkin et shunt mystérieux

Une LLC qui ne sait pas dire son diagnostic ?

Suchergebnisse filtern